RecruitingPhase 4

TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant

United States200 participantsStarted 2018-10-04

Plain-language summary

This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients ages 18 years or older * Renal Transplant Recipients Exclusion Criteria: * Patients less than 18 years of age * Pregnant Women * Prisoners * Opioid Tolerant Patients taking more than 30 mg/day of oral morphine equivalent analgesia * Patients on Systemic anti coagulation * Patients unable to provide consent * Hypersensitivity to amide-type local anesthetic or any component of the drug formula

What they're measuring

Difference in Total Opioid Consumption

Timeframe: Through 4 days following renal transplant surgery

Trial details

NCT IDNCT03737604

SponsorUniversity of California, Davis

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-12

Contact for this trial

Ana Arias, BS

916-703-5456 apaarias@ucdavis.edu

View on ClinicalTrials.gov More Transplant;Failure,Kidney trials